New Silkroutes plans independent review of deals signed with China entity
Fiona Lam
Singapore
HEALTHCARE and energy firm New Silkroutes Group will appoint an independent public accounting firm to review matters relating to two of its agreements involving a China unit, and the valuation of its stake in a Thai firm.
This comes after independent external auditor Deloitte & Touche included a disclaimer of opinion on the group's financial statements for the fiscal year ended June 30.
TRENDING NOW
Singapore staff first to go in Meta’s 8,000 global job cuts
Xi Jinping has just rewritten the rules of US-China rivalry
‘Even a CEO’s job can be replaced by AI’: DBS CEO Tan Su Shan bets big on agentic AI
OpenAI picks Singapore for first Applied AI Lab outside US in S$300 million push to tap ‘incredible talent here’